Pelage

Pelage

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://www.pelagepharma.com

Last Round

Series B

Oct 15, 2025

Total Funding Raised

$150.75M

Company Overview

Pelage is a regenerative medicine company that offers non-invasive treatments aimed at promoting hair health and enabling hair regrowth for individuals experiencing various hair loss conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B2C

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

hair loss treatmentalopecia treatmentregenerative medicinesmall molecule therapyhair follicle stem cellstopical treatmentstem cell reactivationhair regrowth therapyandrogenetic alopeciapattern baldnesschemotherapy-induced alopeciaMPC inhibitorclinical-stage biotechhair follicle stem cell therapymitochondrial pyruvate carrier inhibitor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pelage Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pelage Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 15, 2025
Series A ExtensionAug 13, 2024
Series AFeb 27, 2024

Key People

Founding team and executive leadership

Daniel Gil

Chief Executive Officer

Executive Team

Pelage Investors

Notable investors and investment history

InvestorRounds
GVSeries B, Series A, Series A Extension
Main Street AdvisorsSeries B, Series A, Series A Extension
ARCH Venture PartnersSeries B
Visionary VenturesSeries B, Series A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2025

    Richard Heyman joins the board of directors.

Pelage Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pelage Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pelage's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range11
Year Founded2018
Last FundingOct 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.